Finance

Beta
Lists
301393:SHE
Suzhou Highfine Biotech Co Ltd
CNÂ¥66.57
-5.22%
(-3.67) 1D
Jul 16, 3:04:49 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301393...
Open
CNÂ¥67.69
High
CNÂ¥69.48
Low
CNÂ¥65.36
Mkt. cap
7.68B
Avg. vol.
3.08M
Volume
5.69M
Dividend
0.61%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 21, 2026
P/E ratio
63.27
52-wk high
CNÂ¥74.68
52-wk low
CNÂ¥46.69
EPS
CNÂ¥1.05
Shares outstanding
108.00M
No. of employees
678
Open
CNÂ¥67.69
High
CNÂ¥69.48
Low
CNÂ¥65.36
Mkt. cap
7.68B
Avg. vol.
3.08M
Volume
5.69M
Dividend
0.61%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 21, 2026
P/E ratio
63.27
52-wk high
CNÂ¥74.68
52-wk low
CNÂ¥46.69
EPS
CNÂ¥1.05
Shares outstanding
108.00M
No. of employees
678
News stories
From sources across the web
About Suzhou Highfine Biotech Co Ltd
CEO-
Employees678
FoundedDec 2, 2003
Headquarters-
SectorPharmaceutical industry
Websitehighfine.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
135.09M
164.40M
167.56M
171.93M
Cost of goods sold
78.78M
104.78M
132.84M
110.89M
Cost of revenue
78.78M
104.78M
132.84M
110.89M
Research and development expenses
9.40M
11.35M
10.32M
10.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.99M
20.49M
9.78M
16.37M
Operating expense
21.97M
24.71M
31.28M
28.58M
Total operating expenses
100.76M
129.48M
164.13M
139.47M
Operating income
34.33M
34.92M
3.43M
32.47M
Other non operating income
997.16K
-5.48M
6.81M
-3.34M
EBT including unusual items
46.75M
26.71M
15.44M
37.63M
EBT excluding unusual items
42.00M
38.29M
11.00M
32.52M
Income tax expense
5.66M
3.35M
3.84M
4.92M
Effective tax rate
12.11%
12.56%
24.85%
13.06%
Other operating expenses
673.93K
-2.35M
7.73M
433.75K
Net income
41.09M
23.35M
15.41M
33.44M
Net profit margin
30.41%
14.21%
9.20%
19.45%
Earnings per share
-
-
-
-
Interest and investment income
8.06M
7.95M
8.28M
3.55M
Interest expense
-22.84K
-454.89K
-193.75K
-152.49K
Net interest expenses
8.04M
7.49M
8.09M
3.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
40.83M
39.48M
12.45M
41.48M
Gain or loss from assets sale
93.99K
-93.99K
907.51K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer